SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced the availability of the most widely cited gene expression microarray for use on the GeneAtlas® Personal Microarray System, bringing the power of the world’s largest collection of referenced microarray gene expression data to the personal bench-top of every life scientist. The new array strip format for the GeneChip® Human Genome (HG)-U133 Array combined with the easy workflow of the GeneAtlas System gives researchers a cost-effective solution for in-house whole-genome expression analysis.
